The probiotic Bifidobacterium in the management of Coronavirus: A theoretical basis | Zendy

Hüseyin Sancar Bozkurt | Zendy; Eamonn M.M. Quigley | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The probiotic Bifidobacterium in the management of Coronavirus: A theoretical basis

Author(s) -

Hüseyin Sancar Bozkurt,

Eamonn M.M. Quigley

Publication year - 2020

Publication title -

international journal of immunopathology and pharmacology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.724

H-Index - 53

eISSN - 2058-7384

pISSN - 0394-6320

DOI - 10.1177/2058738420961304

Subject(s) - immune system , cytokine storm , probiotic , immunology , cytokine , bifidobacterium , coronavirus , gastrointestinal tract , bacteria , microbiology and biotechnology , respiratory tract , lactobacillus casei , medicine , biology , lactobacillus , covid-19 , disease , respiratory system , infectious disease (medical specialty) , genetics

COVID-19 is a viral pandemic that primarily manifests with respiratory distress but may also lead to symptoms and signs associated with the gastrointestinal tract. It is characteristically associated with a hyper-immune response, also referred to as a ‘cytokine storm’. Probiotics are living microorganisms that have been shown to have positive effects on immune response in man with some bacteria; some strains of Bifidobacteria, for example, possess especially potent immune modulating effects. These bacteria have the potential to ameliorate the ‘cytokine storm’ through a differential effect on pro- and anti-inflammatory cytokines. In the management of COVID-19 and other coronovirus-mediated illnesses, probiotic bacteria also have the potential to enhance vaccine efficacy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research